Evidence map›Paper›PMID 39741343›Full record

ArticleTrials2024

Health checks for autistic adults: study protocol for a cluster randomised controlled trial.

Jeremy R Parr, Helen Taylor, Colin Wilson, Clare Scarlett, Sarah Al-Asmori, Carole Buckley, Sally-Ann Cooper, Cristina Fernandez-Garcia, Tracy Finch, Rhianna Lees and 10 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jeremy R ParrPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. Jeremy.Parr@newcastle.ac.uk.
Helen TaylorPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0002-2847-9661
Colin WilsonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Clare ScarlettNHS North East and North Cumbria Integrated Care Board, Newcastle upon Tyne, UK.
Sarah Al-AsmoriPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Carole BuckleyRoyal College of General Practitioners, London, UK.
Sally-Ann CooperSchool of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Cristina Fernandez-GarciaPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Tracy FinchDepartment of Nursing, Midwifery and Health, Northumbria University, Newcastle upon Tyne, UK.
Rhianna LeesPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Nicholas LennoxQueensland Centre for Intellectual and Developmental Disability, MRI-UQ, The University of Queensland, Brisbane, QLD, Australia.
Hannah MerrickPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Sebastian MossNHS Northumberland Clinical Commissioning Group, Morpeth, UK.
Christina NicolaidisSchool of Social Work, Portland State University, Portland, OR, USA.
Malcolm OsbourneThe Kayaks Support Group, South Shields, UK.
Dora M RaymakerRegional Research Institute for Human Sciences, Portland State University, Portland, OR, USA.
Tomos RobinsonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Anna UrbanowiczAustralia Institute for Health Transformation, Determinants of Health, School of Health and Social Development, Faculty of Health, Deakin University, Geelong, VIC, Australia.
James M S WasonPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Barry InghamPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutistic people commonly have physical and mental health conditions. They also frequently experience barriers to accessing healthcare, contributing to problems identifying and treating health conditions. These factors may lead to increased and earlier morbidity and lower average life expectancy for autistic people. Health checks specifically designed for autistic people, incorporating adjustments to healthcare, may help to overcome these barriers and reduce health inequalities. This trial aims to investigate the clinical and cost-effectiveness of a primary care health check for autistic adults and explore factors related to implementation such as acceptability and feasibility of delivery. The trial is co-designed and delivered by health professionals, autistic people, carers and supporters, and researchers.

methodsThis is a clinical and cost-effectiveness, cluster randomised controlled trial of a primary care health check for autistic adults. Primary care practices will be randomised into one of two groups (intervention or control). Two hundred autistic adults (aged 18 years and over) who provide baseline data will be recruited via participating practices. Data will be collected through quantitative and qualitative methods. The primary outcome will be the incidence of new health needs/conditions detected and met at 9 months (data gathered from participant's GP records). Secondary outcomes will include the following: cost-effectiveness, measured as incremental cost per quality-adjusted life year gained over 9 months; the extent of health monitoring and health promotion needs met at 9 months; the incidence of social care needs identified at 9 months; changes in participant or carer general health; changes in quality of life; primary and secondary health and social care resource usage and costs. A qualitative study will explore views about the acceptability of the health check, its utility and future use. DISCUSSION: This study will examine the effectiveness and cost-effectiveness of a primary care health check for autistic adults in identifying new health conditions and needs. If the intervention is effective, it would provide strong evidence for implementation into routine healthcare, therefore enabling earlier health condition diagnosis and opportunities for treatment, reducing the health inequalities experienced by autistic people.

trial registrationISRCTN, retrospectively registered on 20 July 2023. https://www.isrctn.com/ISRCTN30156776 (ISRCTN registration number: 30156776).

Indexed as

Autistic DisorderPrimary Health CareAdultCost-Benefit AnalysisHealth Care CostsHumansQuality-Adjusted Life YearsQuality of LifeRandomized Controlled Trials as TopicTime FactorsAutismHealth checksInterventionRCT

Identifiers

PMID39741343
PMCPMC11686900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.